TP53 and cancer: Functional identification of p53 inhibitor synoviolin in A549 cells allowed us to investigate our hypothesis that reactivating endogenous p53 through silencing a p53 inhibitor using RNAi could enhance adenovirus propagation and oncolytic effect in cancer cells.